Top-News

Mauna Kea Technologies News

Aktie
WKN:  A1JCLA ISIN:  FR0010609263 US-Symbol:  MKEAF
0,363 €
+0,0025 €
+0,69%
19.06.24
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

Unternehmensmeldungen

13.06.24 - Businesswire
Mauna Kea Technologies Reports New Evidence Highly Supportive of the Use of Cellvizio for Diagnosing Pancreatic Cysts Presented at DDW 2024
Regulatory News:
07.06.24 - Businesswire
Mauna Kea Technologies Announces Results of Its Combined General Meeting of June 6, 2024
Regulatory News:
06.06.24 - Businesswire
Mauna Kea Technologies Announces Joint Venture in China Obtained Class II Medical Device Business License
Regulatory News:
30.05.24 - Businesswire
Mauna Kea Technologies Winner of “Best New Technology Solution – Oncology” MedTech Breakthrough Award
Regulatory News:
21.05.24 - Businesswire
Mauna Kea Technologies Announces the Availability of Preparatory Documents for the Combined General Meeting of June 6, 2024 and the Instructions for Participation
Regulatory News:
17.05.24 - Businesswire
Mauna Kea Technologies: Monthly information regarding the total number of voting rights and shares comprising the share capital
Regulatory News:
06.05.24 - Businesswire
Mauna Kea Technologies Announces 9 Presentations Demonstrating the Clinical Value of Cellvizio® at Digestive Disease Week® 2024
Regulatory News:
30.04.24 - Businesswire
Mauna Kea Technologies: Publication of the 2023 Annual Financial Report
Regulatory News:
29.04.24 - Businesswire
Mauna Kea Technologies Announces the Opening of a French Center of Excellence for the Use of Cellvizio® in Lung Cancer Diagnostics
Regulatory News:
25.04.24 - Businesswire
Mauna Kea Technologies Reports Full Year 2023 Results and Q1 2024 Sales
Regulatory News:
24.04.24 - Businesswire
Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank
Regulatory News:
04.04.24 - Businesswire
Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
Regulatory News:
02.04.24 - Businesswire
Mauna Kea Technologies Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults
Regulatory News:
27.03.24 - Businesswire
Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio
Regulatory News:
21.06.19 - DGAP
Mauna Kea Technologies SA (MKEA-FR): Reimbursement decision facilitates Cellvizio penetration in France
goetzpartners securities Limited Mauna Kea Technologies SA (MKEA-FR): Reimbursement decision facilitates Cellvizio penetration in France 21-Jun-2019 / 07:53 GMT/BST
26.04.19 - DGAP
Mauna Kea Technologies SA (MKEA-FR): Progressing toward long-term strategic growth
goetzpartners securities Limited Mauna Kea Technologies SA (MKEA-FR): Progressing toward long-term strategic growth 26-Apr-2019 / 08:56 GMT/BST
09.04.19 - DGAP
Mauna Kea Technologies SA (MKEA-FR): FY2018 results validate move to consignment sales
goetzpartners securities Limited Mauna Kea Technologies SA (MKEA-FR): FY2018 results validate move to consignment sales 09-Apr-2019 / 07:55 GMT/BST
18.01.19 - DGAP
Mauna Kea Technologies SA (MKEA-FR): Q4 performance generating momentum for 2019
goetzpartners securities Limited Mauna Kea Technologies SA (MKEA-FR): Q4 performance generating momentum for 2019 18-Jan-2019 / 10:52 GMT/BST
22.10.18 - DGAP
Mauna Kea Technologies SA (MKEA-FR): Q3 sales indicate growing momentum:
goetzpartners securities Limited Mauna Kea Technologies SA (MKEA-FR): Q3 sales indicate growing momentum: 22-Oct-2018 / 16:45 GMT/BST
25.09.18 - DGAP
Mauna Kea Technologies SA (MKEA-FR): H1 results reflect continued focus on the US
goetzpartners securities Limited Mauna Kea Technologies SA (MKEA-FR): H1 results reflect continued focus on the US 25-Sep-2018 / 15:58 GMT/BST

Newssuche

Videos

newspaper
19.06.24 +2,21%
Technical Trading: 95%-Chance mit DAX Short
DAX Short Typ: Unlimited Turbo WKN: JK7KUF Hebel: 4,7 Laufzeit: OpenEnd Einstieg: Market ... Mehr »